marbofloxacin has been researched along with carbostyril in 80 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 14 (17.50) | 18.2507 |
2000's | 64 (80.00) | 29.6817 |
2010's | 2 (2.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Petracca, K; Wanner, M | 1 |
Graser, T; Petracca, K; Riond, JL; Wanner, M | 1 |
Cotard, JP; Deleforge, J; Gruet, P; Moreau, P; Pages, JP; Pechereau, D; Thomas, E | 1 |
Boisramé, B; Deleforge, J; Drugeon, H; Spreng, M; Thomas, V | 1 |
Dubreuil, L; Houcke, I; Leroy, I | 1 |
Boisrame, B; Deleforge, J; Schneider, M; Thomas, V | 1 |
Autefage, A; Gruet, P; Richard, P; Thomas, E | 1 |
Aberlin, S; Biichlé, S; Seillès, E; Spehner, V | 1 |
Glickman, A; Saran, A; Shem-Tov, M; Ziv, G | 1 |
Dupouy, V; Laroute, V; Lefebvre, HP; Schneider, M; Toutain, PL | 1 |
Dossin, O; Gruet, P; Thomas, E | 1 |
Costes, G; Delesalle, L; Dupouy, V; Laroute, V; Lefebvre, HP; Schneider, M; Toutain, PL | 1 |
Carlotti, DN; Guaguere, E; Guiral, V; Jasmin, P; Pin, D; Thomas, E | 1 |
Aramayona, JJ; Bregante, MA; Garcia, MA; Rueda, S; Solans, C | 1 |
AliAbadi, FS; Lees, P | 3 |
González Lama, Z; Lupiola Gómez, P; Martín Barrasa, JL; Tejedor Junco, MT | 1 |
Davot, JL; Grandemange, E; Pommier, P; Thomas, E; Wessel-Robert, S | 1 |
Evans, EI; Frazier, DL; Thompson, L; Trettien, A | 1 |
Carbone, M; De Sarro, A; Fera, MT; Giannone, M; Masucci, M; Pennisi, MG | 1 |
Abbey, L; Baker, B; Coyne, M; Hannigan, M; Joffe, D; Paradis, M; Pukay, B; Trettien, A; Waisglass, S; Wellington, J | 1 |
Garcia-Montijano, M; González, F; Quetglas, J; Rodríguez, C; San Andrés, MI; Sánchez, C; Waxman, S | 1 |
Borell, D; Caldow, GL; Davot, JL; Thomas, E | 1 |
Borrull, F; Calull, M; Hernández, M | 1 |
Heinen, E | 1 |
De Vicente, ML; González, F; Rodríguez, C; San Andrés, MD; San Andrés, MI; Waxman, S | 1 |
Carretero, M; de Lucas, JJ; Forés, P; González, F; Nieto, J; Rodríguez, C; San Andrés, MD; San Andrés, MI; Waxman, S | 1 |
Bernard, S; Bousquet-Melou, A; Schneider, M; Toutain, PL | 1 |
Anadón, A; Castellano, VJ; Díaz, MJ; Frejo, MT; Martínez, M; Martínez, MA; Martínez-Larrañaga, MR; Tafur, M | 1 |
De Lucas, JJ; González, F; Rodríguez, C; San Andrés, MD; San Andrés, MI; Waxman, S | 2 |
Boisramé, B; Concordet, D; Regnier, A; Schneider, M; Toutain, PL | 1 |
Dederichs, D; Hirt, RA; Teinfalt, M; van den Hoven, R | 1 |
Boisramé, B; Schneider, M; Vallé, M; Woehrlé, F | 1 |
Horspool, LJ; Mawhinney, I; van den Bos, R; van Laar, P | 1 |
Acar, JF; Kroemer, S; Martel, JL; Meunier, D; Vallé, M | 2 |
Bousquet-Mélou, A; Concordet, D; Doucet, MY; Peyrou, M; Schneider, M; Vrins, A | 1 |
Chaslus-Dancla, E; Cloeckaert, A; Olliver, A; Vallé, M | 1 |
Landoni, MF; Lees, P; Sidhu, PK | 2 |
Bidgood, TL; Papich, MG | 1 |
Gicquel-Bruneau, M; Laurentie, M; Pellet, T; Sanders, P | 1 |
Albarellos, GA; Landoni, MF; Montoya, L | 1 |
Bender, JB; Gilbert, SM; LeDell, KH; Olsen, KE; Torres, SM | 1 |
Boisramé, B; Borell, D; Pheulpin, S; Rougier, S; Woehrlé, F | 1 |
Dugas, B; Mazier, D; Pino, P; Rougier, S; Vouldoukis, I; Woehrlé, F | 1 |
de Lucas, JJ; González, F; Rodríguez, C; San Andrés, MI; Uriarte, I; Waxman, S | 1 |
Boeckh, A; Boothe, DM; Boothe, HW; Jones, SA; Stenstrom, KK; Wilkie, WS | 1 |
Catone, T; Coni, E; Fabrizi, L; Ligabue, M; Lucchetti, D; Marvasi, L; Zaghini, A | 1 |
Chanoit, GP; Lefebvre, HP; Schneider, M; Woehrlé, F | 1 |
Bensignor, E; Grandemange, E | 1 |
Caney, SM; Day, MJ; Dean, RS; Gruffydd-Jones, TJ; Helps, CR; Knowles, TG; Lait, PJ; Pinches, MD; Tasker, S | 2 |
Boucher, S; Boussarie, D; Galland, D; Rougier, S; Vallé, M | 1 |
Andrés, MI; Garcia-Montijano, M; González, F; Luaces, I; Lucas, JJ; Rodríguez, C; Waxman, S; Zalba, J | 1 |
Bengoumi, M; Bounaga, R; El Hraiki, A; Laraje, R; Laurentie, M; Talmi, A | 1 |
Gautier-Bouchardon, AV; Kobisch, M; Laurentie, M; Le Carrou, J | 1 |
Carpenter, JW; Henry, H; Hunter, RP; Isaza, R; Koch, DE; Olsen, JH | 1 |
De Lucas, JJ; Dova, SW; González, F; Rodríguez, C; San Andrés, MD; San Andrés, MI | 1 |
Boulouis, HJ; Cariou, M; Moissonnier, P | 1 |
Fink-Gremmels, J; Haritova, AM; Lashev, LD; Parvanov, PR; Rusenova, NV | 1 |
Bousquet-Melou, A; Doucet, MY; Laroute, V; Peyrou, M; Vrins, A | 1 |
Blikslager, AT; Davis, JL; Little, D; Papich, MG | 1 |
Ensink, JM; van Duijkeren, E; van Soest, JM; Voermans, M | 1 |
El-Kattan, YA; Ismail, M | 1 |
Huff, D; KuKanich, B; Papich, MG; Riviere, JE | 1 |
Coke, RL; Hunter, RP; Isaza, R; Koch, DE; Pellerin, MA | 1 |
Carpenter, JW; Coke, RL; Hunter, RP; Isaza, R; Koch, DE | 1 |
Cavana, P; Farca, AM; Nebbia, P; Robino, P | 1 |
De Lucas, JJ; González, F; Nieto, J; Rodríguez, C; San Andrés, MD; San Andrés, MI; Serres, C; Waxman, S | 1 |
Bousquet-Mélou, A; Dupouy, V; Ferran, A; Toutain, PL | 1 |
Cox, SK | 1 |
Art, T; Bedoret, D; de Moffarts, B; Lekeux, P; van Erck, E | 1 |
Chen, X; Hua, H; Ji, C; Lin, X; Liu, Y; Tang, S; Yue, Z | 1 |
Concordet, D; Regnier, A; Schneider, M; Toutain, PL | 1 |
Bousquet-Mélou, A; Ferran, AA; Kesteman, AS; Toutain, PL | 1 |
Companyó, R; Guiteras, J; Jiménez, V | 1 |
Assié, S; Bousquet-Mélou, A; Dupouy, V; El Garch, F; Lhermie, G; Ravinet, N; Seegers, H; Toutain, PL | 1 |
1 review(s) available for marbofloxacin and carbostyril
Article | Year |
---|---|
Antibiotic treatment for animals: effect on bacterial population and dosage regimen optimisation.
Topics: Animal Diseases; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Microbial; Fluoroquinolones; Quinolones; Ruminants | 2000 |
19 trial(s) available for marbofloxacin and carbostyril
Article | Year |
---|---|
Comparative study of marbofloxacin and amoxicillin-clavulanic acid in the treatment of urinary tract infections in dogs.
Topics: Administration, Oral; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Infective Agents; Bacteria; Clavulanic Acids; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Fluoroquinolones; Injections, Subcutaneous; Male; Quinolones; Recurrence; Treatment Outcome; Urinary Tract Infections | 1995 |
Therapy of difficult cases of canine pyoderma with marbofloxacin: a report of 39 dogs.
Topics: Animals; Anti-Infective Agents; Body Weight; Cellulitis; Dog Diseases; Dogs; Enzyme Inhibitors; Erythema; Female; Fluoroquinolones; Folliculitis; Follow-Up Studies; Male; Microbial Sensitivity Tests; Pruritus; Pyoderma; Quinolones; Recurrence; Skin Ulcer; Staphylococcal Infections; Treatment Outcome | 1999 |
Field evaluation of efficacy and tolerance of a 2% marbofloxacin injectable solution for the treatment of respiratory disease in fattening pigs.
Topics: Amoxicillin; Animals; Anti-Infective Agents; Bacteria; Body Temperature; Drug Evaluation; Europe; Fluoroquinolones; Injections, Intramuscular; Penicillins; Quinolones; Respiratory Tract Diseases; Solutions; Swine; Swine Diseases; Time Factors; Treatment Outcome | 2000 |
Comparison of fluoroquinolone pharmacokinetic parameters after treatment with marbofloxacin, enrofloxacin, and difloxacin in dogs.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Area Under Curve; Ciprofloxacin; Cross-Over Studies; Dogs; Enrofloxacin; Female; Fluoroquinolones; Quinolones; Skin | 2000 |
Activity and postantibiotic effect of marbofloxacin, enrofloxacin, difloxacin and ciprofloxacin against feline Bordetella bronchiseptica isolates.
Topics: Animals; Anti-Infective Agents; Bordetella bronchiseptica; Bordetella Infections; Cat Diseases; Cats; Ciprofloxacin; Enrofloxacin; Female; Fluoroquinolones; Male; Microbial Sensitivity Tests; Quinolones | 2001 |
A field comparison of the efficacy and tolerance of marbofloxacin in the treatment of bovine respiratory disease.
Topics: Analysis of Variance; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Belgium; Cattle; Disease Outbreaks; Dose-Response Relationship, Drug; Drug Tolerance; Enzyme Inhibitors; Female; Fluoroquinolones; France; Macrolides; Mannheimia haemolytica; Pasteurella multocida; Pasteurellosis, Pneumonic; Quinolones; Tylosin | 2001 |
Population pharmacokinetics of marbofloxacin in aqueous humor after intravenous administration in dogs.
Topics: Animals; Anti-Infective Agents; Aqueous Humor; Dog Diseases; Dogs; Eye Diseases; Female; Fluoroquinolones; Half-Life; Injections, Intravenous; Male; Quinolones | 2003 |
Treatment of canine pyoderma with ibafloxacin and marbofloxacin--fluoroquinolones with different pharmacokinetic profiles.
Topics: Administration, Oral; Animals; Dog Diseases; Dogs; Drug Administration Schedule; Europe; Fluoroquinolones; Pyoderma; Quinolizines; Quinolones; Severity of Illness Index; Treatment Outcome; Veterinary Drugs | 2004 |
Population pharmacokinetics of marbofloxacin in horses: preliminary analysis.
Topics: Animals; Anti-Infective Agents; Area Under Curve; Enzyme Inhibitors; Female; Fluoroquinolones; Gastritis; Horse Diseases; Horses; Injections, Intramuscular; Male; Mastitis; Quinolones; Regression Analysis; Respiratory Tract Infections; Topoisomerase II Inhibitors | 2004 |
Pharmacokinetic and pharmacodynamic interactions of tolfenamic acid and marbofloxacin in goats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Cross-Over Studies; Dinoprostone; Drug Interactions; Enzyme Inhibitors; Exudates and Transudates; Female; Fluoroquinolones; Goats; Inflammation; Leukocytes; ortho-Aminobenzoates; Quinolones | 2006 |
Plasma and interstitial fluid pharmacokinetics of enrofloxacin, its metabolite ciprofloxacin, and marbofloxacin after oral administration and a constant rate intravenous infusion in dogs.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Area Under Curve; Ciprofloxacin; Cross-Over Studies; Dogs; Enrofloxacin; Extracellular Fluid; Female; Fluoroquinolones; Infusions, Intravenous; Quinolones | 2005 |
A comparative study of two antimicrobial/anti-inflammatory formulations in the treatment of canine otitis externa.
Topics: Administration, Topical; Animals; Anti-Infective Agents, Local; Anti-Inflammatory Agents; Clotrimazole; Dexamethasone; Dog Diseases; Dogs; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Male; Microbial Sensitivity Tests; Otitis Externa; Quinolones; Treatment Outcome | 2005 |
Pharmacokinetics of marbofloxacin after intravenous and intramuscular administration to ostriches.
Topics: Absorption; Animals; Area Under Curve; Chromatography, High Pressure Liquid; Cross-Over Studies; Enzyme Inhibitors; Fluoroquinolones; Half-Life; Injections, Intramuscular; Injections, Intravenous; Metabolic Clearance Rate; Quinolones; Struthioniformes | 2005 |
Effect of chronic feline immunodeficiency infection, and efficacy of marbofloxacin treatment, on 'Candidatus Mycoplasma haemominutum' infection.
Topics: Animals; Anti-Bacterial Agents; Cat Diseases; Cats; DNA, Bacterial; Drug Administration Schedule; Female; Fluoroquinolones; Lentivirus Infections; Male; Mycoplasma; Mycoplasma Infections; Quinolones; Specific Pathogen-Free Organisms | 2006 |
Comparative pharmacokinetics of marbofloxacin after a single intramuscular administration at two dosages to camels (Camelus dromedarius).
Topics: Animals; Anti-Infective Agents; Area Under Curve; Camelus; Chromatography, High Pressure Liquid; Fluoroquinolones; Injections, Intramuscular; Male; Quinolones | 2006 |
Pharmacokinetics of marbofloxacin in blue and gold macaws (Ara ararauna).
Topics: Administration, Oral; Animals; Area Under Curve; Biological Availability; Female; Fluoroquinolones; Half-Life; Injections, Intravenous; Male; Psittaciformes; Quinolones | 2006 |
Comparative pharmacokinetics of marbofloxacin in healthy and Mannheimia haemolytica infected calves.
Topics: Animals; Area Under Curve; Case-Control Studies; Cattle; Enzyme Inhibitors; Fluoroquinolones; Health; Mannheimia haemolytica; Microbial Sensitivity Tests; Pasteurellaceae Infections; Quinolones | 2007 |
Preliminary single-dose pharmacokinetics of marbofloxacin in ball pythons (Python regius).
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Area Under Curve; Biological Availability; Boidae; Chromatography, Liquid; Cross-Over Studies; Female; Fluoroquinolones; Injections, Intravenous; Male; Mass Spectrometry; Quinolones | 2006 |
Impact of Low and High Doses of Marbofloxacin on the Selection of Resistant Enterobacteriaceae in the Commensal Gut Flora of Young Cattle: Discussion of Data from 2 Study Populations.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cattle Diseases; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Feces; Fluoroquinolones; Gastrointestinal Microbiome; Gastrointestinal Tract; Male; Microbial Sensitivity Tests; Quinolones | 2017 |
60 other study(ies) available for marbofloxacin and carbostyril
Article | Year |
---|---|
[The effect of pregnancy and lactation in sows on the pharmacokinetics of the gyrase inhibitor marbofloxacin].
Topics: Administration, Oral; Animals; Anti-Infective Agents; Female; Fluoroquinolones; Injections, Intravenous; Lactation; Pregnancy; Pregnancy, Animal; Quinolones; Swine; Topoisomerase II Inhibitors | 1993 |
Pharmacokinetics of the gyrase inhibitor marbofloxacin: influence of pregnancy and lactation in sows.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Female; Fluoroquinolones; Injections, Intravenous; Lactation; Pregnancy; Pregnancy, Animal; Quinolones; Swine; Topoisomerase II Inhibitors | 1993 |
Antibacterial activity of marbofloxacin. A new fluoroquinolone for veterinary use against canine and feline isolates.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacteriuria; Cat Diseases; Cats; Dog Diseases; Dogs; Enzyme Inhibitors; Escherichia coli; Fluoroquinolones; Microbial Sensitivity Tests; Pasteurella multocida; Quinolones; Staphylococcus; Staphylococcus aureus; Topoisomerase II Inhibitors | 1995 |
[In vitro activity of a new fluoroquinolone, marbofloxacin (RO 09-1168) against strictly anaerobic bacteria and some bacteria from human fecal flora].
Topics: Anti-Infective Agents; Bacteria, Anaerobic; Dose-Response Relationship, Drug; Enterococcus; Escherichia coli; Feces; Fluoroquinolones; Humans; In Vitro Techniques; Lactobacillus; Ofloxacin; Proteus; Quinolones; Topoisomerase II Inhibitors | 1996 |
Pharmacokinetics of marbofloxacin in dogs after oral and parenteral administration.
Topics: Administration, Oral; Analysis of Variance; Animals; Anti-Infective Agents; Biological Availability; Chromatography, High Pressure Liquid; Cross-Over Studies; Dogs; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Injections, Intravenous; Injections, Subcutaneous; Male; Quinolones; Reference Standards; Skin | 1996 |
Prevention of surgical infections in dogs with a single intravenous injection of marbofloxacin: an experimental model.
Topics: Animals; Anti-Infective Agents; Dogs; Female; Fluoroquinolones; Injections, Intravenous; Male; Quinolones; Staphylococcal Infections; Surgical Wound Infection | 1997 |
[Study of the membrane oxidative response of phagocytes after treatment with marbofloxacin in healthy cattle].
Topics: Adjuvants, Immunologic; Animals; Anti-Infective Agents; Cattle; Fluoroquinolones; Hydrocortisone; Luminescent Measurements; Phagocytes; Quinolones; Respiratory Burst; Serum Albumin, Bovine | 1996 |
Pharmacokinetics and penetration of marbofloxacin from blood into the milk of cows and ewes.
Topics: Animals; Anti-Infective Agents; Cattle; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Half-Life; Injections, Intramuscular; Injections, Intravenous; Milk; Quinolones; Sheep; Time Factors | 1997 |
Pharmacokinetics of marbofloxacin in renal impairment in the dog.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Dog Diseases; Dogs; Female; Fluoroquinolones; Quinolones; Renal Insufficiency | 1998 |
Comparative field evaluation of marbofloxacin tablets in the treatment of feline upper respiratory infections.
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Infective Agents; Cat Diseases; Cats; Fluoroquinolones; Quinolones; Random Allocation; Respiratory Tract Infections; Treatment Outcome | 1998 |
Effect of experimental renal impairment on disposition of marbofloxacin and its metabolites in the dog.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Area Under Curve; Creatinine; Dog Diseases; Dogs; Female; Fluoroquinolones; Glomerular Filtration Rate; Injections, Intravenous; Quinolones; Renal Insufficiency; Urea | 1998 |
Determination of marbofloxacin in plasma samples by high-performance liquid chromatography using fluorescence detection.
Topics: Anti-Infective Agents; Chromatography, High Pressure Liquid; Fluoroquinolones; Quinolones; Reference Standards; Reproducibility of Results; Spectrometry, Fluorescence | 1999 |
Antibacterial susceptibility patterns of Pseudomonas strains isolated from chronic canine otitis externa.
Topics: Animals; Anti-Bacterial Agents; Ceftazidime; Chronic Disease; Dog Diseases; Dogs; Drug Resistance, Microbial; Fluoroquinolones; Microbial Sensitivity Tests; Otitis Externa; Pseudomonas; Pseudomonas Infections; Quinolones; Tobramycin | 2000 |
Evaluation of the clinical efficacy of marbofloxacin (Zeniquin) tablets for the treatment of canine pyoderma: an open clinical trial.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Breeding; Canada; Dog Diseases; Dogs; Female; Fluoroquinolones; Male; Pyoderma; Quinolones; Severity of Illness Index; Staphylococcal Infections; Treatment Outcome | 2001 |
The disposition of marbofloxacin in Eurasian buzzards (Buteo buteo) after intravenous administration.
Topics: Animals; Anti-Infective Agents; Area Under Curve; Enzyme Inhibitors; Fluoroquinolones; Half-Life; Injections, Intravenous; Quinolones; Raptors | 2001 |
Using nonaqueous capillary electrophoresis to analyze several quinolones in pig kidney samples.
Topics: Animals; Anti-Infective Agents; Calibration; Ciprofloxacin; Electrophoresis, Capillary; Enrofloxacin; Fluoroquinolones; Kidney; Molecular Structure; Oxolinic Acid; Quinolizines; Quinolones; Swine | 2002 |
Comparative serum pharmacokinetics of the fluoroquinolones enrofloxacin, difloxacin, marbofloxacin, and orbifloxacin in dogs after single oral administration.
Topics: Animals; Anti-Infective Agents; Area Under Curve; Ciprofloxacin; Cross-Over Studies; Dogs; Enrofloxacin; Female; Fluoroquinolones; Male; Microbial Sensitivity Tests; Quinolones | 2002 |
Pharmacokinetic behavior of marbofloxacin after intravenous and intramuscular administrations in adult goats.
Topics: Animals; Anti-Infective Agents; Area Under Curve; Biological Availability; Chromatography, High Pressure Liquid; Cross-Over Studies; Female; Fluoroquinolones; Goats; Injections, Intramuscular; Injections, Intravenous; Quinolones; Topoisomerase II Inhibitors | 2001 |
Pharmacokinetics and pharmacokinetic/pharmacodynamic integration of marbofloxacin in calf serum, exudate and transudate.
Topics: Animals; Anti-Infective Agents; Area Under Curve; Carrageenan; Cattle; Cross-Over Studies; Dose-Response Relationship, Drug; Exudates and Transudates; Fluoroquinolones; Injections, Intramuscular; Injections, Intravenous; Lipopolysaccharides; Male; Mannheimia haemolytica; Microbial Sensitivity Tests; Quinolones; Tissue Distribution | 2002 |
Marbofloxacin in equine medicine: have we got the doses right?
Topics: Animals; Anti-Infective Agents; Biological Availability; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Administration Schedule; Fluoroquinolones; Horses; Intestinal Absorption; Metabolic Clearance Rate; Quinolones | 2002 |
Pharmacokinetics of marbofloxacin in mature horses after single intravenous and intramuscular administration.
Topics: Absorption; Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Biological Availability; Chromatography, High Pressure Liquid; Colony Count, Microbial; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Horse Diseases; Horses; Injections, Intramuscular; Injections, Intravenous; Male; Metabolic Clearance Rate; Quinolones; Reference Values; Tissue Distribution; Treatment Outcome | 2002 |
Pharmacokinetics of marbofloxacin in horses.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Colony Count, Microbial; Cross-Over Studies; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Horse Diseases; Horses; Injections, Intravenous; Injections, Subcutaneous; Intestinal Absorption; Male; Metabolic Clearance Rate; Microbial Sensitivity Tests; Nutritive Value; Quinolones; Random Allocation; Treatment Outcome | 2002 |
Pharmacokinetic characteristics and tissue residues for marbofloxacin and its metabolite N-desmethyl-marbofloxacin in broiler chickens.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Area Under Curve; Biological Availability; Chickens; Drug Residues; Fluoroquinolones; Half-Life; Injections, Intravenous; Kidney; Liver; Male; Muscles; Quinolones; Random Allocation; Skin | 2002 |
Influence of Escherichia coli endotoxin-induced fever on the pharmacokinetic behavior of marbofloxacin after intravenous administration in goats.
Topics: Animals; Anti-Infective Agents; Area Under Curve; Chromatography, High Pressure Liquid; Endotoxins; Escherichia coli; Female; Fever; Fluoroquinolones; Goat Diseases; Goats; Injections, Intravenous; Quinolones; Topoisomerase II Inhibitors | 2003 |
The effect of orally administered marbofloxacin on the pharmacokinetics of theophylline.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Area Under Curve; Bronchodilator Agents; Delayed-Action Preparations; Dogs; Dose-Response Relationship, Drug; Drug Interactions; Female; Fluoroquinolones; Male; Quinolones; Theophylline | 2003 |
Pharmacokinetics of marbofloxacin in lactating cows after repeated intramuscular administrations and pharmacodynamics against mastitis isolated strains.
Topics: Animals; Cattle; Chromatography, High Pressure Liquid; Escherichia coli; Female; Fluoroquinolones; Injections, Intramuscular; Kinetics; Lactation; Mastitis, Bovine; Microbial Sensitivity Tests; Milk; Quinolones; Staphylococcus aureus | 2004 |
Age-related changes in the pharmacokinetics of marbofloxacin after intravenous administration in goats.
Topics: Aging; Animals; Animals, Newborn; Area Under Curve; Chromatography, High Pressure Liquid; Enzyme Inhibitors; Female; Fluoroquinolones; Goats; Injections, Intravenous; Quinolones; Topoisomerase II Inhibitors | 2004 |
Seven years survey of susceptibility to marbofloxacin of bovine pathogenic strains from eight European countries.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cattle; Cattle Diseases; Drug Resistance, Bacterial; Enteritis; Escherichia coli; Europe; Fluoroquinolones; Haemophilus somnus; Mannheimia haemolytica; Mastitis, Bovine; Microbial Sensitivity Tests; Pasteurella multocida; Quinolones; Respiratory Tract Infections; Salmonella; Staphylococcus aureus; Streptococcus | 2004 |
A seven-year survey of susceptibility to marbofloxacin of pathogenic strains isolated from pets.
Topics: Animals; Animals, Domestic; Cat Diseases; Cats; Data Collection; Dog Diseases; Dogs; Drug Resistance, Bacterial; Escherichia coli; Fluoroquinolones; Microbial Sensitivity Tests; Quinolones | 2004 |
Overexpression of the multidrug efflux operon acrEF by insertional activation with IS1 or IS10 elements in Salmonella enterica serovar typhimurium DT204 acrB mutants selected with fluoroquinolones.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Carrier Proteins; Cattle; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Enrofloxacin; Fluoroquinolones; Gene Expression Regulation, Bacterial; Membrane Transport Proteins; Microbial Sensitivity Tests; Molecular Sequence Data; Mutagenesis, Insertional; Mutation; Operon; Quinolones; Salmonella typhimurium | 2005 |
Influence of marbofloxacin on the pharmacokinetics and pharmacodynamics of tolfenamic acid in calves.
Topics: Animals; Animals, Newborn; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Cattle; Diffusion Chambers, Culture; Drug Combinations; Drug Interactions; Fluoroquinolones; Injections, Intramuscular; Male; ortho-Aminobenzoates; Quinolones; Topoisomerase II Inhibitors | 2005 |
Comparison of faecal and optimal growth conditions on in vitro pharmacodynamic activity of marbofloxacin against Escherichia coli.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Escherichia coli; Escherichia coli Infections; Feces; Fluoroquinolones; Microbial Sensitivity Tests; Poultry Diseases; Quinolones; Swine; Swine Diseases; Turkeys | 2006 |
Pharmacokinetics of marbofloxacin after single intravenous and repeat oral administration to cats.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Biological Availability; Cats; Fluoroquinolones; Injections, Intravenous; Quinolones; Statistics as Topic | 2005 |
Isolation of methicillin-resistant Staphylococcus aureus from a non-healing abscess in a cat.
Topics: Abscess; Animals; Cat Diseases; Cats; Diagnosis, Differential; Enzyme Inhibitors; Fluoroquinolones; Foot; Forelimb; Male; Methicillin Resistance; Quinolones; Staphylococcal Skin Infections; Staphylococcus aureus; Topoisomerase II Inhibitors | 2005 |
Canine visceral leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate.
Topics: Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fibroblasts; Fluoroquinolones; Interleukin-6; Leishmania infantum; Leishmaniasis, Visceral; Macrophages; Meglumine; Meglumine Antimoniate; Mice; Nitric Oxide; Organometallic Compounds; Parasitic Sensitivity Tests; Quinolones; Tumor Necrosis Factor-alpha | 2006 |
Evaluation of the concentration of marbofloxacin in alveolar macrophages and pulmonary epithelial lining fluid after administration in dogs.
Topics: Administration, Oral; Animals; Bronchoalveolar Lavage Fluid; Bronchoscopy; Chromatography, High Pressure Liquid; Dogs; Fluoroquinolones; Macrophages, Alveolar; Quinolones; Time Factors | 2005 |
Rapid depletion of marbofloxacin residues in rabbit after therapeutic treatment.
Topics: Animals; Anti-Infective Agents; Chromatography, High Pressure Liquid; Consumer Product Safety; Dose-Response Relationship, Drug; Drug Residues; Enzyme Inhibitors; Fluoroquinolones; Kidney; Liver; Male; Muscles; Organ Specificity; Quinolones; Rabbits; Tissue Distribution | 2005 |
Effect of marbofloxacin on cardiovascular variables in healthy isoflurane-anesthetized dogs.
Topics: Analysis of Variance; Anesthesia, Inhalation; Animals; Blood Pressure; Chromatography, High Pressure Liquid; Dogs; Fluoroquinolones; Heart Rate; Injections, Intravenous; Isoflurane; Quinolones; Stroke Volume; Vascular Resistance | 2005 |
Comparison of an antifungal agent with a mixture of antifungal, antibiotic and corticosteroid agents for the treatment of Malassezia species otitis in dogs.
Topics: Administration, Topical; Adrenal Cortex Hormones; Animals; Anti-Bacterial Agents; Antifungal Agents; Chi-Square Distribution; Clotrimazole; Dermatomycoses; Dexamethasone; Dog Diseases; Dogs; Drug Combinations; Female; Fluoroquinolones; Malassezia; Male; Miconazole; Otitis Externa; Quinolones; Treatment Outcome | 2006 |
Epidemiology and susceptibility of pathogenic bacteria responsible for upper respiratory tract infections in pet rabbits.
Topics: Animals; Animals, Domestic; Anti-Bacterial Agents; Bordetella bronchiseptica; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Fluoroquinolones; Microbial Sensitivity Tests; Nasal Mucosa; Pasteurella multocida; Pseudomonas; Quinolones; Rabbits; Respiratory Tract Infections; Staphylococcus | 2006 |
The pharmacokinetic behaviour of marbofloxacin in Eurasian buzzards (Buteo buteo) after intraosseous administration.
Topics: Animals; Anti-Infective Agents; Area Under Curve; Enzyme Inhibitors; Fluoroquinolones; Half-Life; Infusions, Intraosseous; Quinolones; Raptors | 2006 |
Persistence of Mycoplasma hyopneumoniae in experimentally infected pigs after marbofloxacin treatment and detection of mutations in the parC gene.
Topics: Animals; Anti-Bacterial Agents; DNA Topoisomerase IV; DNA, Bacterial; Drug Resistance, Bacterial; Enrofloxacin; Fluoroquinolones; Microbial Sensitivity Tests; Mutation; Mycoplasma hyopneumoniae; Mycoplasma Infections; Oxytetracycline; Quinolones; Sequence Analysis, DNA; Specific Pathogen-Free Organisms; Swine; Trachea; Tracheal Diseases | 2006 |
Pharmacokinetic behavior and pharmacokinetic/pharmacodynamic integration of marbofloxacin after subcutaneous administration in goats.
Topics: Animals; Area Under Curve; Chromatography, High Pressure Liquid; Enzyme Inhibitors; Fluoroquinolones; Goats; Half-Life; Injections, Subcutaneous; Quinolones | 2007 |
Inclusion of marbofloxacin in PMMA orthopaedic cement: an in vitro experimental study.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bone Cements; Enzyme Inhibitors; Feasibility Studies; Fluoroquinolones; In Vitro Techniques; Microbial Sensitivity Tests; Osteomyelitis; Polymethyl Methacrylate; Quinolones; Treatment Outcome | 2006 |
Effect of chronic FIV infection, and efficacy of marbofloxacin treatment, on Mycoplasma haemofelis infection.
Topics: Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Chronic Disease; Colony Count, Microbial; Feline Acquired Immunodeficiency Syndrome; Female; Fluoroquinolones; Male; Mycoplasma; Mycoplasma Infections; Polymerase Chain Reaction; Quinolones; Random Allocation; Time Factors; Treatment Outcome; Viral Load | 2006 |
Integration of pharmacokinetic and pharmacodynamic indices of marbofloxacin in turkeys.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Area Under Curve; Chromatography, High Pressure Liquid; Cross-Over Studies; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Injections, Intravenous; Male; Microbial Sensitivity Tests; Quinolones; Serum Bactericidal Test; Turkeys | 2006 |
Enrofloxacin and marbofloxacin in horses: comparison of pharmacokinetic parameters, use of urinary and metabolite data to estimate first-pass effect and absorbed fraction.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Area Under Curve; Biological Availability; Ciprofloxacin; Enrofloxacin; Enzyme Inhibitors; Female; Fluoroquinolones; Half-Life; Horses; Injections, Intravenous; Quinolones | 2006 |
Mucosal permeability of water-soluble drugs in the equine jejunum: a preliminary investigation.
Topics: Animals; Anti-Infective Agents; Biological Availability; Cephalexin; Fluconazole; Fluoroquinolones; Horses; Intestinal Mucosa; Jejunum; Linear Models; Metronidazole; Permeability; Quinolones; Solubility | 2006 |
Clinical efficacy of intravenous administration of marbofloxacin in a Staphylococcus aureus infection in tissue cages in ponies.
Topics: Animals; Chromatography, High Pressure Liquid; Colony Count, Microbial; Diffusion Chambers, Culture; Enzyme Inhibitors; Fluoroquinolones; Horse Diseases; Horses; Injections, Intravenous; Male; Microbial Sensitivity Tests; Quinolones; Staphylococcal Infections; Staphylococcus aureus; Topoisomerase II Inhibitors | 2006 |
Naïve averaged, naïve pooled, and population pharmacokinetics of orally administered marbofloxacin in juvenile harbor seals.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Area Under Curve; Biological Availability; Chromatography, High Pressure Liquid; Enzyme Inhibitors; Female; Fluoroquinolones; Male; Metabolic Clearance Rate; Models, Biological; Phoca; Quinolones | 2007 |
Identification and comparison of marbofloxacin metabolites from the plasma of ball pythons (Python regius) and blue and gold macaws (Ara ararauna).
Topics: Administration, Oral; Animals; Anti-Infective Agents; Birds; Boidae; Chromatography, Liquid; Feces; Female; Fluoroquinolones; Injections, Intravenous; Male; Mass Spectrometry; Quinolones; Species Specificity | 2007 |
In vitro antimicrobial activity of marbofloxacin and enrofloxacin against bacterial strains isolated from companion animals.
Topics: Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Colony Count, Microbial; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Enrofloxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Quinolones; Treatment Outcome | 2007 |
Pharmacokinetics of a single intravenous dose of marbofloxacin in adult donkeys.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Bacterial Infections; Equidae; Female; Fluoroquinolones; Half-Life; Horse Diseases; Horses; Injections, Intravenous; Male; Metabolic Clearance Rate; Quinolones; Species Specificity; Treatment Outcome | 2007 |
Influence of inoculum size on the selection of resistant mutants of Escherichia coli in relation to mutant prevention concentrations of marbofloxacin.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Escherichia coli; Fluoroquinolones; Microbial Viability; Mutation; Quinolones; Time Factors | 2007 |
Allometric scaling of marbofloxacin, moxifloxacin, danofloxacin and difloxacin pharmacokinetics: a retrospective analysis.
Topics: Animals; Anti-Infective Agents; Area Under Curve; Aza Compounds; Ciprofloxacin; Fluoroquinolones; Humans; Moxifloxacin; Quinolines; Quinolones; Retrospective Studies; Species Specificity | 2007 |
Pulmonary function and antimicrobial concentration after marbofloxacin inhalation in horses.
Topics: Administration, Inhalation; Animals; Biological Availability; Bronchoalveolar Lavage Fluid; Cross-Over Studies; Enzyme Inhibitors; Fluoroquinolones; Horse Diseases; Horses; Injections, Intravenous; Quinolones; Random Allocation; Respiratory Function Tests; Time Factors | 2007 |
[Determination of 16 quinolone residues in animal tissues using high performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry].
Topics: Animals; Chromatography, High Pressure Liquid; Ciprofloxacin; Enoxacin; Enrofloxacin; Fluoroquinolones; Norfloxacin; Ofloxacin; Pefloxacin; Quinolones; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization | 2007 |
Intraocular pharmacokinetics of intravenously administered marbofloxacin in rabbits with experimentally induced acute endophthalmitis.
Topics: Animals; Anti-Infective Agents; Aqueous Humor; Area Under Curve; Disease Models, Animal; Dog Diseases; Dogs; Endophthalmitis; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Half-Life; Injections, Intravenous; Male; Quinolones; Rabbits; Vitreous Body | 2008 |
Pharmacokinetic/pharmacodynamic analysis of the influence of inoculum size on the selection of resistance in Escherichia coli by a quinolone in a mouse thigh bacterial infection model.
Topics: Animals; Anti-Bacterial Agents; Cyclophosphamide; Disease Models, Animal; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Mice; Microbial Sensitivity Tests; Polymerase Chain Reaction; Quinolones; Sequence Analysis, DNA; Thigh | 2009 |
Analysis of quinolone antibiotics in eggs: preparation and characterization of a raw material for method validation and quality control.
Topics: Anti-Bacterial Agents; Chromatography, Liquid; Ciprofloxacin; Eggs; Enrofloxacin; Fluoroquinolones; Food Contamination; Norfloxacin; Oxolinic Acid; Quality Control; Quinolones; Reproducibility of Results | 2012 |